Publications

Detailed Information

Vitrification for cryopreservation of 2D and 3D stem cells culture using high concentration of cryoprotective agents

Cited 13 time in Web of Science Cited 14 time in Scopus
Authors

Jeong, Young-Hoon; Kim, Ukjin; Lee, Seul-Gi; Ryu, Bokyeong; Kim, Jin; Igor, Artyuhov; Kim, Jong Soo; Jung, Cho-Rok; Park, Jae-Hak; Kim, C-Yoon

Issue Date
2020-08-26
Publisher
BioMed Central
Citation
BMC Biotechnology, Vol.20 No.1, p. 45
Abstract
Background: Vitrification is the most promising technology for successful cryopreservation of living organisms without ice crystal formation. However, high concentrations (up to similar to 6-8 M) of cryoprotective agents (CPAs) used in stem cell induce osmotic and metabolic injuries. Moreover, the application of conventional slow-freezing methods to cultures of 3-D organoids of stem cells in various studies, is limited by their size. Results: In this study, we evaluated the effect of high concentrations of CPAs including cytotoxicity and characterized human mesenchymal stem cell (MSC) at single cell level. The cell viability, cellular damage, and apoptotic mechanisms as well as the proliferation capacity and multipotency of cells subjected to vitrification were similar to those in the slow-freezing group. Furthermore, we identified the possibility of vitrification of size-controlled 3-D spheroids for cryopreservation of organoid with high survivability. Conclusions: Our results demonstrate successful vitrification of both single cell and spheroid using high concentration of CPAs in vitro without cytotoxicity.
ISSN
1472-6750
URI
https://hdl.handle.net/10371/194745
DOI
https://doi.org/10.1186/s12896-020-00636-9
Files in This Item:
There are no files associated with this item.
Appears in Collections:

Related Researcher

  • College of Veterinary Medicine
  • Department of Veterinary Medicine
Research Area Laboratory Animal Medicine, Toxicologic Pathology

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share